Johnson & Johnson (JNJ) Invested Capital (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Invested Capital data on file, last reported at $98.6 billion in Q1 2026.

• Quarterly Invested Capital rose 7.22% year-over-year to $98.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.6 billion (up 7.22% YoY) and the FY2025 annual result came in at $123.0 billion, up 18.38% from the prior year.
• Invested Capital eased to $98.6 billion in Q1 2026 per JNJ's latest filing, from $123.0 billion in the prior quarter.
• The five-year high for Invested Capital was $123.0 billion in Q4 2025, with the low at $74.6 billion in Q3 2024.
• Average Invested Capital over 5 years is $90.3 billion, with a median of $88.5 billion recorded in 2023.
• Year-over-year, Invested Capital dropped 11.57% in 2024 and grew 18.38% in 2025.
• Johnson & Johnson's Invested Capital stood at $79.0 billion in 2022, then advanced by 21.64% to $96.1 billion in 2023, then increased by 8.08% to $103.9 billion in 2024, then advanced by 18.38% to $123.0 billion in 2025, then fell by 19.79% to $98.6 billion in 2026.
• Business Quant data shows JNJ's Invested Capital at $98.6 billion in Q1 2026, $123.0 billion in Q4 2025, and $85.7 billion in Q3 2025.